Cargando…
Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome
SIMPLE SUMMARY: This pilot study on the trajectory of the gut microbiota (GM) in patients with epithelial ovarian cancer undergoing neoadjuvant and adjuvant chemotherapy highlighted peculiar dynamics associated with the therapeutic outcome. In particular, platinum-resistant patients showed a marked...
Autores principales: | D’Amico, Federica, Perrone, Anna Myriam, Rampelli, Simone, Coluccelli, Sara, Barone, Monica, Ravegnini, Gloria, Fabbrini, Marco, Brigidi, Patrizia, De Iaco, Pierandrea, Turroni, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393652/ https://www.ncbi.nlm.nih.gov/pubmed/34439153 http://dx.doi.org/10.3390/cancers13163999 |
Ejemplares similares
-
Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives
por: Barone, Monica, et al.
Publicado: (2021) -
Gut microbiota resilience and recovery after anticancer chemotherapy
por: Roggiani, Sara, et al.
Publicado: (2023) -
Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out
por: Conti, Gabriele, et al.
Publicado: (2022) -
Polyphenol and Tannin Nutraceuticals and Their Metabolites: How the Human Gut Microbiota Influences Their Properties
por: Fabbrini, Marco, et al.
Publicado: (2022) -
Gut microbiome–micronutrient interaction: The key to controlling the bioavailability of minerals and vitamins?
por: Barone, Monica, et al.
Publicado: (2022)